Accéder au contenu
Merck

Identification of disease-relevant modulators of the SHH pathway in the developing brain.

Development (Cambridge, England) (2021-09-01)
Nora Mecklenburg, Izabela Kowalczyk, Franziska Witte, Jessica Görne, Alena Laier, Tamrat M Mamo, Hannes Gonschior, Martin Lehmann, Matthias Richter, Anje Sporbert, Bettina Purfürst, Norbert Hübner, Annette Hammes
RÉSUMÉ

Pathogenic gene variants in humans that affect the sonic hedgehog (SHH) pathway lead to severe brain malformations with variable penetrance due to unknown modifier genes. To identify such modifiers, we established novel congenic mouse models. LRP2-deficient C57BL/6N mice suffer from heart outflow tract defects and holoprosencephaly caused by impaired SHH activity. These defects are fully rescued on a FVB/N background, indicating a strong influence of modifier genes. Applying comparative transcriptomics, we identified Pttg1 and Ulk4 as candidate modifiers upregulated in the rescue strain. Functional analyses showed that ULK4 and PTTG1, both microtubule-associated proteins, are positive regulators of SHH signaling, rendering the pathway more resilient to disturbances. In addition, we characterized ULK4 and PTTG1 as previously unidentified components of primary cilia in the neuroepithelium. The identification of genes that powerfully modulate the penetrance of genetic disturbances affecting the brain and heart is likely relevant to understanding the variability in human congenital disorders.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Mélange de marquage d′ARN à la DIG, sufficient for 20 reactions, solution
Sigma-Aldrich
Anticorps monoclonal de souris anti-tubuline acétylée antibody produced in mouse, clone 6-11B-1, purified from hybridoma cell culture
Sigma-Aldrich
Alcool polyvinylique, 87-90% hydrolyzed, average mol wt 30,000-70,000
Sigma-Aldrich
Anti-γ-Tubulin antibody, Mouse monoclonal, clone GTU-88, ascites fluid
Sigma-Aldrich
Anti-α-Tubulin Mouse mAb (DM1A), liquid, clone DM1A, Calbiochem®
Sigma-Aldrich
Cyclopamine-KAAD, Cyclopamine- KAAD, CAS 306387-90-6, is a cell-permeable potent analog of Cyclopamine (Cat. No. 239803) that specifically inhibits Hedgehog (Hh) signaling with similar or lower toxicity (IC₅₀ = 20 nM).